International Journal of Physical Medicine & Rehabilitation: treating chronic pain with Hilterapia®

04 July 2016 - Trade fairs & Congresses -

Chronic pain, that is a pain lasting for longer than 3 months, requires appropriate treatment. The International Journal of Physical Medicine & Rehabilitation reports an article by Areerat Suputtitad, a Physiatrist at the Chulalongkorn Memorial Hospital in Bangkok, explaining that Hilterapia® is capable of reaching and stimulating damaged cells and tissues. Its effectiveness is made possible by amplifying the photonic energy produced by a single directional laser beam capable of acting in-depth the Hilterapia® anti-inflammatory and analgesic effects provide relief from pain from the earliest treatments.

You might also be interested in ...

See all articles

Press - 29/11/2018
The press agency Italpress reports the success of the course sponsored by FIS - Federazione Italiana Scherma (Italian Fencing Federation), dedicated to traumatology in sports, with an extensive focus...
Press - 12/10/2018
The ASAlaser “highly technological” devices and the efficient therapeutic solutions are at home for the Taiwan national team (Chinese Taipei) at the Indonesia 2018 Asian Para Games. The...
Press - 08/10/2018
Doctor Alessandro Danieli, in charge of the Fisiodanieli centre, a specialist medical centre in Rome, has no doubts when interviewed by the capital’s magazine “In Roma”, controlled...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.